These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 9577408

  • 1. Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva.
    Lanchoney TF, Olmsted EA, Shore EM, Gannon FA, Rosen V, Zasloff MA, Kaplan FS.
    Clin Orthop Relat Res; 1998 Jan; (346):38-45. PubMed ID: 9577408
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.
    Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS.
    N Engl J Med; 1996 Aug 22; 335(8):555-61. PubMed ID: 8678932
    [Abstract] [Full Text] [Related]

  • 3. Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.
    Ahn J, Feldman G, Terry L, Shore EM, Kaplan FS.
    Clin Orthop Relat Res; 2003 Jan 22; (406):205-13. PubMed ID: 12579020
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of bone and cartilage related genes in fibrodysplasia ossificans progressiva, myositis ossificans traumatica, and osteogenic sarcoma.
    Shafritz AB, Kaplan FS.
    Clin Orthop Relat Res; 1998 Jan 22; (346):46-52. PubMed ID: 9577409
    [Abstract] [Full Text] [Related]

  • 5. Mutational screening of the bone morphogenetic protein 4 gene in a family with fibrodysplasia ossificans progressiva.
    Xu M, Shore EM.
    Clin Orthop Relat Res; 1998 Jan 22; (346):53-8. PubMed ID: 9577410
    [Abstract] [Full Text] [Related]

  • 6. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis.
    Ahn J, Serrano de la Pena L, Shore EM, Kaplan FS.
    J Bone Joint Surg Am; 2003 Apr 22; 85(4):667-74. PubMed ID: 12672843
    [Abstract] [Full Text] [Related]

  • 7. Embryonic overexpression of the c-Fos protooncogene. A murine stem cell chimera applicable to the study of fibrodysplasia ossificans progressiva in humans.
    Olmsted EA, Gannon FH, Wang ZQ, Grigoriadis AE, Wagner EF, Zasloff MA, Shore EM, Kaplan FS.
    Clin Orthop Relat Res; 1998 Jan 22; (346):81-94. PubMed ID: 9577414
    [Abstract] [Full Text] [Related]

  • 8. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Fiori JL, Billings PC, de la Peña LS, Kaplan FS, Shore EM.
    J Bone Miner Res; 2006 Jun 22; 21(6):902-9. PubMed ID: 16753021
    [Abstract] [Full Text] [Related]

  • 9. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.
    de la Peña LS, Billings PC, Fiori JL, Ahn J, Kaplan FS, Shore EM.
    J Bone Miner Res; 2005 Jul 22; 20(7):1168-76. PubMed ID: 15940369
    [Abstract] [Full Text] [Related]

  • 10. Bone morphogenetic protein-4 regulation in fibrodysplasia ossificans progressiva.
    Olmsted EA, Kaplan FS, Shore EM.
    Clin Orthop Relat Res; 2003 Mar 22; (408):331-43. PubMed ID: 12616078
    [Abstract] [Full Text] [Related]

  • 11. Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva.
    Gannon FH, Valentine BA, Shore EM, Zasloff MA, Kaplan FS.
    Clin Orthop Relat Res; 1998 Jan 22; (346):19-25. PubMed ID: 9577406
    [Abstract] [Full Text] [Related]

  • 12. Urinary basic fibroblast growth factor. A biochemical marker for preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressiva.
    Kaplan F, Sawyer J, Connors S, Keough K, Shore E, Gannon F, Glaser D, Rocke D, Zasloff M, Folkman J.
    Clin Orthop Relat Res; 1998 Jan 22; (346):59-65. PubMed ID: 9577411
    [Abstract] [Full Text] [Related]

  • 13. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
    Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG.
    J Bone Joint Surg Am; 2007 Feb 22; 89(2):347-57. PubMed ID: 17272450
    [Abstract] [Full Text] [Related]

  • 14. Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva.
    Calvert GT, Shore EM.
    Clin Orthop Relat Res; 1998 Jan 22; (346):66-70. PubMed ID: 9577412
    [Abstract] [Full Text] [Related]

  • 15. Bone morphogenetic proteins with some comments on fibrodysplasia ossificans progressiva and NOGGIN.
    Cohen MM.
    Am J Med Genet; 2002 Apr 22; 109(2):87-92. PubMed ID: 11977155
    [No Abstract] [Full Text] [Related]

  • 16. Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva.
    Zaghloul KA, Heuer GG, Guttenberg MD, Shore EM, Kaplan FS, Storm PB.
    J Neurosurg Pediatr; 2008 Jan 22; 1(1):91-4. PubMed ID: 18352811
    [Abstract] [Full Text] [Related]

  • 17. [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].
    Katagiri T, Kamizono J, Nakashima Y, Kitoh H, Susami T, Haga N.
    Clin Calcium; 2010 Oct 22; 20(10):1510-7. PubMed ID: 20890033
    [Abstract] [Full Text] [Related]

  • 18. Fibrodysplasia ossificans progressiva.
    Blaszczyk M, Majewski S, Brzezinska-Wcislo L, Jablonska S.
    Eur J Dermatol; 2003 Oct 22; 13(3):234-7. PubMed ID: 12804980
    [Abstract] [Full Text] [Related]

  • 19. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.
    Fatehi AN, van den Hurk R, Colenbrander B, Daemen AJ, van Tol HT, Monteiro RM, Roelen BA, Bevers MM.
    Theriogenology; 2005 Feb 22; 63(3):872-89. PubMed ID: 15629804
    [Abstract] [Full Text] [Related]

  • 20. Mast cell involvement in fibrodysplasia ossificans progressiva.
    Gannon FH, Glaser D, Caron R, Thompson LD, Shore EM, Kaplan FS.
    Hum Pathol; 2001 Aug 22; 32(8):842-8. PubMed ID: 11521229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.